WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 9'206  8'925  8'442  7'718  6'799  3'026  1'806  1'015 
Births 131  129  124  117  108  50  47  29 
Surviving infants 130  128  123  116  108  49  46  28 
Pop. less than 5 years 647  605  538  495  430  259  225  131 
Pop. less than 15 years 1'366  1'282  1'170  1'127  1'055  768  558  285 
Female 15-49 years 1'960  1'909  1'824  1'651  1'446  562  317  153 

Number of reported case

(Click for retrospective incidence data for United Arab Emirates (the))
Diphtheria 20 
Japanese encephalitis
Measles 132  87  55  69  1'187  2'796 
Mumps 377  396  477  732 
Pertussis 61  79  51  37  96  228 
Polio* 48 
Rubella 30  34  70  52 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 14 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for United Arab Emirates (the))
Vaccine year result method % card seen                                                
BCG 1994  97  FHS   72.4  94  98  98  98  15 
DTP1 1994  93  FHS   72.4  99*  94  96 
DTP3 1994  85  FHS   72.4  99*  94  92  94  11 
HepB_BD          96  98  98  98 
HepB3 1994  76  FHS   72.4  99*  94  92  92 
Hib3          99*  94  92  92 
JapEnc         
MCV 1994  83  FHS   72.4  99*  94  94  34 
MCV2          99*  94  92  92 
PCV1          99*  94 
PCV3          99*  94 
Pol3 1994  86  FHS   72.4  99*  94  94  94  11 
Rota1         
Rota_last         
Rubella1         
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for United Arab Emirates (the))
BCG 94  96  98  98  98  98  96  15 
DTP1 94  94  94  95  96  96  95  32 
DTP3 94  94  94  93  92  94  85  11 
HepB3 94  94  94  93  92  92 
Hib3 94  94  94  93  92  92 
MCV 94  94  94  93  92  94  80  34 
PCV3 94  94  94 
Pol3 94  94  94  94  94  94  85  11 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 15-16 years; Yes
DTwPHib 2, 4, 6 months; Yes
DTwPHibIPV 18 months; Yes
Dip 5-6 years;
HepA Yes risk groups
HepB birth; 2, 4, 6 months;
Hib 18 months; Yes
IPV 2 months;
Influenza Yes Haj, Omrah pilgrims and risk group
MMR 12 months; 5-6 years; Yes
MenACWY Yes Haj and Omra and risk groups
OPV 4, 6, 18 months; 5-6 years; Yes
Pneumo_conj 2,4, 6, 18 months; Yes
Pneumo_ps Yes high risk groups
Rubella 13-14 years; Yes girls
Typhoid Yes high risk groups and travellers
Varicella 12 months; Yes and risk groups
YF Yes high risk groups

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR YES    Yes    Yes     
What years does the MYP cover? number 5 YR        3 years     
Nº of districts with microplans that include activities to raise immunization coverage number        

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR YES             

System performance

Total number of districts in country number        
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100% 100        100     
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100% 100           

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR YES        No     
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND YES             

Finance

Percentage of routine vaccines funded by Government From 0 to 100%         100     

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.